THÔNG TIN TÀI LIỆU
Ngày đăng: 04/12/2022, 16:05
Xem thêm:
Mục lục
Genetic modification of purified primary human duct cells
Figure™1Oncogenic KRAS expression and tumour suppressor inactivation immortalizes purified primary human duct cells.(a) Schematic diagram summarizing experimental procedures. (b) FACS histogram of the dissociated human adult pancreas stained with antibody
Development of PanIN-like lesions after transplantation
Development of PanIN2-like lesions with ERBB2 in hiPanINs
Figure™2Genetically modified human ductal cells develop PanIN-like lesions after orthotopic transplantation.(a) Schematic diagram of the orthotopic transplantation procedure. (b) immunohistochemical analyses of a PanIN-like structure in transplanted anima
Figure™3Expression of ERBB2 and oncogenic KRAS along with tumour suppressor inactivation immortalizes purified primary human duct cells.(a) Schematic of lentiviral constructs encoding H2B-mCherry and human ERBB2. (b) Genomic DNA PCR confirming the presenc
Cloned hiPanIN cells produce PanIN-like lesions
Figure™4Development of PanIN2-like lesions after orthotopic transplantation of transduced primary human ductal KECST spheres.(a) Haematoxylin and eosin (H&E) staining of transplanted mouse pancreas ID 185 with S2 KECST spheres. (b) Magnified image of the
Genetic modification of HPDE cells induces PDA development
Figure™5Clones with defined genomic mutations form PanIN-like lesions but not PDA.(a) Schematic of the sphere clone isolation procedure. See Methods for details. (b) Genomic DNA PCR confirming the presence of lentiviral transgenes in clone 3 (left) and cl
TÀI LIỆU CÙNG NGƯỜI DÙNG
TÀI LIỆU LIÊN QUAN